AOLS Aeolus Pharmaceuticl

USD 0.00 0.00 0
Icon

Aeolus Pharmaceuticl (AOLS) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.00

0.00 (0.00)%

USD 0.17M

N/A

N/A

N/A

Icon

AOLS

Aeolus Pharmaceuticl (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.17M

N/A

USD 0.00

Aeolus Pharmaceuticl (AOLS) Stock Forecast

N/A

Based on the Aeolus Pharmaceuticl stock forecast from 0 analysts, the average analyst target price for Aeolus Pharmaceuticl is not available over the next 12 months. Aeolus Pharmaceuticl’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aeolus Pharmaceuticl is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Aeolus Pharmaceuticl’s stock price was USD 0.00. Aeolus Pharmaceuticl’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Aeolus Pharmaceuticl
No recent average analyst rating found for Aeolus Pharmaceuticl

Company Overview Aeolus Pharmaceuticl

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as me...Read More

26361 Crown Valley Parkway, Mission Viejo, CA, United States, 92691

4

September

USD

USA

Adjusted Closing Price for Aeolus Pharmaceuticl (AOLS)

Loading...

Unadjusted Closing Price for Aeolus Pharmaceuticl (AOLS)

Loading...

Share Trading Volume for Aeolus Pharmaceuticl Shares

Loading...

Compare Performance of Aeolus Pharmaceuticl Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AOLS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aeolus Pharmaceuticl (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKKGY
Merck KGaA ADR 0.00 (0.00%) USD76.46B 23.93 14.17

ETFs Containing AOLS

Symbol Name AOLS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aeolus Pharmaceuticl (AOLS) Stock

Stock Target Advisor's fundamental analysis for Aeolus Pharmaceuticl's stock is Slightly Bearish.

AOLS stock's dividend yield is 0.13%. Our analysis grades AOLS stock's dividend yield at F. This means that AOLS stock's dividend yield is above 3% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this AOLS may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on AOLS's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on AOLS's stock to indicate if its overvalued.

The last closing price of AOLS's stock was USD 0.00.

The most recent market capitalization for AOLS is USD 0.17M.

Unfortunately we do not have enough analyst data on AOLS's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Aeolus Pharmaceuticl's stock.

As per our most recent records Aeolus Pharmaceuticl has 4 Employees.

Aeolus Pharmaceuticl's registered address is 26361 Crown Valley Parkway, Mission Viejo, CA, United States, 92691. You can get more information about it from Aeolus Pharmaceuticl's website at https://www.aeoluspharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...